Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026
Description
Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026
The global CRO services market is estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of clinical trials, high cost of in-house drug development (encouraging pharma-biotech companies to opt for outsourcing), and the rising prevalence of orphan and rare diseases (creating new revenue pockets for CROs).
“The data management services segment accounted for the highest growth rate in the CRO services market, by type, during the forecast period”
In 2021, the data management services segment accounted for the highest growth rate. The data management services segment is projected to grow at the highest CAGR owing to the need for the generation of high-quality and statistically sound data and its management and the rising importance of data handling in order to meet regulatory requirements. Data management is critical for smooth and uninterrupted flow and easy access of data during the development of drugs and medical devices.
“Asia Pacific: The fastest-growing region in the CRO services market”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. This is attributed to the rapid growth in the pharmaceutical and biopharmaceutical industries, low cost of clinical trials, implementation of favorable government policies, and the rising number of CROs in the region.
The primary interviews conducted for this report can be categorized as follows:
By Respondent:
Supply Side- 70% and Demand Side 30%
By Designation:
C-level - 45%, D-level - 30%, and Others - 25%
By Region:
North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
IQVIA Inc. (US)
Laboratory Corporation of America Holdings (US)
Charles River Laboratories International Inc. (US)
WuXi AppTec Co. Ltd. (China)
Syneos Health Inc. (US)
PPD, Inc. ( a part of Thermo Fisher Scientific, Inc.)
Parexel International Corporation (US)
ICON plc (Ireland)
Medpace Holdings Inc. (US)
SGS SA (Switzerland)
BioAgile Therapeutics Pvt. Ltd. (India)
Firma Clinical Research, LLC (US)
AccuLab Life Sciences (US)
Novotech Health Holdings (Australia)
Geneticist Inc. (US)
Linical Americas (US)
Celerion (US)
Azelix LLC (US)
Pepgra Healthcare Pvt. Ltd. (UK)
Dove Quality Solutions Limited (UK)
Frontage Holdings Corporation (US)
PSI CRO AG (Switzerland)
Pharmaron Beijing Co., Ltd. (China)
Clinipace Inc. (US)
Axcent Advanced Analytics (US)
Clinical Trial Service BV (Netherlands)
Research Coverage:
This report provides a detailed picture of the global Contract Research Organization (CROs) Services Market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Contract Research Organization (CROs) Services Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, challenges, trends, and opportunities.
The global CRO services market is estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of clinical trials, high cost of in-house drug development (encouraging pharma-biotech companies to opt for outsourcing), and the rising prevalence of orphan and rare diseases (creating new revenue pockets for CROs).
“The data management services segment accounted for the highest growth rate in the CRO services market, by type, during the forecast period”
In 2021, the data management services segment accounted for the highest growth rate. The data management services segment is projected to grow at the highest CAGR owing to the need for the generation of high-quality and statistically sound data and its management and the rising importance of data handling in order to meet regulatory requirements. Data management is critical for smooth and uninterrupted flow and easy access of data during the development of drugs and medical devices.
“Asia Pacific: The fastest-growing region in the CRO services market”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. This is attributed to the rapid growth in the pharmaceutical and biopharmaceutical industries, low cost of clinical trials, implementation of favorable government policies, and the rising number of CROs in the region.
The primary interviews conducted for this report can be categorized as follows:
By Respondent:
Supply Side- 70% and Demand Side 30%
By Designation:
C-level - 45%, D-level - 30%, and Others - 25%
By Region:
North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
IQVIA Inc. (US)
Laboratory Corporation of America Holdings (US)
Charles River Laboratories International Inc. (US)
WuXi AppTec Co. Ltd. (China)
Syneos Health Inc. (US)
PPD, Inc. ( a part of Thermo Fisher Scientific, Inc.)
Parexel International Corporation (US)
ICON plc (Ireland)
Medpace Holdings Inc. (US)
SGS SA (Switzerland)
BioAgile Therapeutics Pvt. Ltd. (India)
Firma Clinical Research, LLC (US)
AccuLab Life Sciences (US)
Novotech Health Holdings (Australia)
Geneticist Inc. (US)
Linical Americas (US)
Celerion (US)
Azelix LLC (US)
Pepgra Healthcare Pvt. Ltd. (UK)
Dove Quality Solutions Limited (UK)
Frontage Holdings Corporation (US)
PSI CRO AG (Switzerland)
Pharmaron Beijing Co., Ltd. (China)
Clinipace Inc. (US)
Axcent Advanced Analytics (US)
Clinical Trial Service BV (Netherlands)
Research Coverage:
This report provides a detailed picture of the global Contract Research Organization (CROs) Services Market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Contract Research Organization (CROs) Services Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, challenges, trends, and opportunities.
Table of Contents
231 Pages
- STUDY OBJECTIVES
- MARKET DEFINITION
- MARKET SCOPE
- CURRENCY
- LIMITATIONS
- STAKEHOLDERS
- RESEARCH DATA
- MARKET SIZE ESTIMATION
- MARKET BREAKDOWN AND DATA TRIANGULATION
- MARKET SHARE ESTIMATION
- STUDY ASSUMPTIONS
- LIMITATIONS
- RISK ASSESSMENT
- ASSESSMENT OF IMPACT OF COVID-19 ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET
- EXECUTIVE SUMMARY
- ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET OVERVIEW
- ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
- NORTH AMERICA: ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT AND COUNTRY (2020)
- REGIONAL MIX: ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET (2021-2026)
- ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: DEVELOPED VS. DEVELOPING MARKETS
- INTRODUCTION
- MARKET DYNAMICS
- INTRODUCTION
- TECHNOLOGY TRENDS
- INDUSTRY TRENDS
- PRICING ANALYSIS
- VALUE CHAIN ANALYSIS
- ECOSYSTEM MAPPING
- SUPPLY CHAIN ANALYSIS
- PORTER'S FIVE FORCES ANALYSIS
- REGULATORY ANALYSIS
- PATENT ANALYSIS
- TRADE ANALYSIS
- IMPACT OF COVID-19 ON THE ENDOSCOPY EQUIPMENT MARKET
- INTRODUCTION
- ENDOSCOPES
- ENDOTHERAPY DEVICES
- VISUALIZATION SYSTEMS
- ENERGY DEVICES
- OTHERS
- INTRODUCTION
- BILIARY SPHINCTEROTOMY
- BILIARY DILATATION
- BILIARY STENTING
- PANCREATIC SPHINCTEROTOMY
- PANCREATIC DUCT DILATATION
- PANCREATIC DUCT STENTING
- INTRODUCTION
- HOSPITALS
- AMBULATORY SURGERY CENTERS/CLINICS
- OTHER END USERS
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC
- LATIN AMERICA
- OVERVIEW
- KEY PLAYER STRATEGIES/RIGHT-TO-WIN
- REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
- COMPETITIVE BENCHMARKING
- COMPETITIVE LEADERSHIP MAPPING
- COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES
- MARKET RANKING ANALYSIS
- COMPETITIVE SCENARIO
- KEY PLAYERS
- OTHER PLAYERS
- DISCUSSION GUIDE
- KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- AVAILABLE CUSTOMIZATIONS
- RELATED REPORTS
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
